During the past decade, Duke CTSI Translational Population Health Office conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke CTSI Translational Population Health Office" #1 collaborator was "North Carolina Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Duke CTSI Translational Population Health Office" are "C3PI Study Testing Group" (1 trials) and "COVID 19" (1 trials). Many other conditions were trialed in "Duke CTSI Translational Population Health Office" in a lesser frequency.

Most popular intervention types in "Duke CTSI Translational Population Health Office" are "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "COVID-19 PCR and serology testing" (1 trials), "Regular Phlebotomy" (1 trials) and "Tasso-SST on Demand" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke CTSI Translational Population Health Office" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Duke CTSI Translational Population Health Office". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Duke CTSI Translational Population Health Office, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Duke CTSI Translational Population Health Office, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".